Cargando…
Correction: L-Arginine in diabetes: clinical and preclinical evidence
Autores principales: | Forzano, Imma, Avvisato, Roberta, Varzideh, Fahimeh, Jankauskas, Stanislovas S., Cioppa, Angelo, Mone, Pasquale, Salemme, Luigi, Kansakar, Urna, Tesorio, Tullio, Trimarco, Valentina, Santulli, Gaetano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197449/ https://www.ncbi.nlm.nih.gov/pubmed/37208744 http://dx.doi.org/10.1186/s12933-023-01852-1 |
Ejemplares similares
-
L-Arginine in diabetes: clinical and preclinical evidence
por: Forzano, Imma, et al.
Publicado: (2023) -
Tirzepatide: A Systematic Update
por: Forzano, Imma, et al.
Publicado: (2022) -
Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure
por: Forzano, Imma, et al.
Publicado: (2022) -
The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension
por: Forzano, Imma, et al.
Publicado: (2022) -
miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections
por: Kansakar, Urna, et al.
Publicado: (2022)